Keyphrases
Asthma
57%
Severe Asthma
45%
Oscillometry
43%
Airway Hyperresponsiveness
34%
Asthma Control
33%
Biologic Therapy
31%
Small Airway Dysfunction
29%
Benralizumab
28%
Asthma Patients
28%
Persistent Asthma
26%
Spirometry
26%
Moderate-to-severe Asthma
24%
Asthma Exacerbation
23%
Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
23%
Airway
23%
Forced Expiratory Volume in 1 Second (FEV1)
22%
Inhaled Corticosteroids
22%
Severe Eosinophilic Asthma
20%
Mannitol
19%
Dupilumab
19%
Type 2 Biomarker
19%
Small Airways
17%
Fractional Exhaled Nitric Oxide (FeNO)
16%
Asthma Phenotypes
16%
Reliever Therapy
16%
Impulse Oscillometry
15%
Budesonide
15%
Mepolizumab
14%
Omalizumab
14%
Anti-inflammatory Reliever
13%
Bronchodilator Response
13%
Bronchial Wall Thickening
13%
Asthma Control Questionnaire
13%
Lung Function
13%
Disease Control
13%
Peripheral Blood Eosinophils
12%
Mucus Plug
11%
Blood Eosinophils
11%
Comorbidity
11%
Nasal Polyps
11%
FEF25-75
10%
Sino-Nasal Outcome Test
10%
Systemic Effects
10%
Polypectomy
10%
Eosinophils
10%
Reactance
9%
Nasal Polyp Score
9%
Minimal Clinically Important Difference
9%
Bronchiectasis
9%
Type 2 Inflammation
8%
Medicine and Dentistry
Asthma
100%
Oscillometry
56%
Severe Asthma
41%
Nasal Polyp
36%
Biological Product
29%
Chronic Rhinosinusitis
27%
Benralizumab
25%
Eosinophilic
23%
Spirometry
19%
Disease
15%
Biological Therapy
15%
Eosinophil
15%
Respiratory Tract Allergy
13%
Endotype
12%
Lung
10%
Immunoglobulin E
9%
Asthma Exacerbation
9%
Mepolizumab
8%
Omalizumab
8%
Polypectomy
8%
Cytokine
8%
Asthma Control Questionnaire
8%
Mannitol
6%
Prospective Cohort Study
6%
B Cell
6%
Bronchodilating Agent
6%
Lung Mechanics
6%
Lymphoproliferative Disease
6%
Retrospective Study
6%
Functional Endoscopic Sinus Surgery
6%
Alarmin
6%
Respiratory System
6%
Asthma in Adults
6%
Asthma in Children
6%
Dupilumab
6%
Recurrent Disease
6%
Nitric Oxide
5%
Body Mass Index
5%
Breathing
5%
Forced Expiratory Volume
5%